L&C BIO Co.,LTD (KOSDAQ:290650)

South Korea flag South Korea · Delayed Price · Currency is KRW
62,600
-2,200 (-3.40%)
May 20, 2026, 3:30 PM KST
Market Cap1.56T +228.1%
Revenue (ttm)85.48B +18.7%
Net Income-138.17B
EPS-5,819.37
Shares Out24.85M
PE Ration/a
Forward PE57.30
Dividend50.00 (0.08%)
Ex-Dividend DateDec 29, 2025
Volume185,099
Average Volume308,519
Open64,400
Previous Close64,800
Day's Range60,000 - 64,400
52-Week Range21,800 - 125,000
Beta1.34
RSI44.29
Earnings DateMar 24, 2026

About L&C BIO Co.,LTD

L&C Bio Co., Ltd operates as a research and development company in tissue regeneration medicine. The company offers pharmaceuticals, human tissue, medical device, and cosmetics products. L&C Bio Co., Ltd was founded in 2011 and is headquartered in Seongnam-si, South Korea. [Read more]

Industry Medical - Specialties
Sector Healthcare
Founded 2011
Employees 141
Stock Exchange KOSDAQ
Ticker Symbol 290650
Full Company Profile

Financial Performance

Financial Statements